fda import alert glp-1 semaglutide tirzepatide green list HIMS Positioned Strongly Amid Crackdown on Unverified GL FDA says that the GLP-1

As with any medication, side effects like nausea, mild gastrointestinal discomfort, or loss of appetite may occur initially but typically lessen over time

Both medications commonly cause gastrointestinal side effects and carry important warnings

Injection site reactions: Mild redness, swelling, or discomfort at injection sites may occur

Individual circumstances and goals should guide this decision

[DOI] [PubMed] [Google Scholar] 116.Irie J., Inagaki E., Fujita M., Nakaya H., Mitsuishi M., Yamaguchi S., Yamashita K., Shigaki S., Ono T., Yukioka H., et al

Metabolic improvement Better metabolic control through improved insulin sensitivity, reduced inflammation, and weight normalization creates a healthier physiological environment for all organ systems, including the thyroid